Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance

NCT01191099 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01191099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01191099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
August 31, 2020
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer